These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6988507)

  • 1. SC5b-9 complex of complement: formation of the dimeric membrane attack complex by removal of S-protein.
    Podack ER; Müller-Eberhard HJ
    J Immunol; 1980 Apr; 124(4):1779-83. PubMed ID: 6988507
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
    Podack ER; Preissner KT; Müller-Eberhard HJ
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of complement activation between tuberculous and malignant pleuritis].
    Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of complement membrane attack complex in normal human corneas.
    Mondino BJ; Chou HJ; Sumner HL
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1576-81. PubMed ID: 8675400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes.
    Li YP; Mold C; Du Clos TW
    J Immunol; 1994 Mar; 152(6):2995-3005. PubMed ID: 8144898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited proteolysis of C5b-6: functional stability of the degraded complex.
    Podack ER; Müller-Eberhard HJ
    J Immunol; 1980 Jan; 124(1):332-6. PubMed ID: 6444229
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T; Meri S
    J Immunol; 1993 Nov; 151(9):4941-9. PubMed ID: 7691959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation during CAPD.
    Young GA; Kendall S; Brownjohn AM
    Nephrol Dial Transplant; 1993; 8(12):1372-5. PubMed ID: 8159307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of complement membrane attack complex formation in myocardial infarction.
    Väkevä A; Laurila P; Meri S
    Am J Pathol; 1993 Jul; 143(1):65-75. PubMed ID: 7686345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
    Balkarowa-Ständer J; Rother U; Rauterberg EW
    J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ultrastructure of cultivable treponemes. 2. Treponema calligyrum, Treponema minutum and Treponema microdentium.
    Hougen KH
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):495-507. PubMed ID: 4528816
    [No Abstract]   [Full Text] [Related]  

  • 14. CD59 efficiently protects human NT2-N neurons against complement-mediated damage.
    Pedersen ED; Aass HC; Rootwelt T; Fung M; Lambris JD; Mollnes TE
    Scand J Immunol; 2007; 66(2-3):345-51. PubMed ID: 17635812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteolysis of the monomeric and dimeric C5b-9 complexes of complement: alteration in the susceptibility to proteases of the C9 subunits associated with C5b-9 dimerization.
    Yamamoto K; Migita S
    J Immunol; 1981 Aug; 127(2):423-6. PubMed ID: 7019323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration.
    Johnson LV; Leitner WP; Staples MK; Anderson DH
    Exp Eye Res; 2001 Dec; 73(6):887-96. PubMed ID: 11846519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation.
    De Vries B; Matthijsen RA; Wolfs TG; Van Bijnen AA; Heeringa P; Buurman WA
    Transplantation; 2003 Feb; 75(3):375-82. PubMed ID: 12589162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
    Brannen CL; Sodetz JM
    Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of inverse plasma filtration on complement activation in porcine blood.
    Haltern C; Kirschfink M; Rossaint R; Unger JK
    Artif Organs; 2005 Apr; 29(4):306-12. PubMed ID: 15787625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.